Authors:
Hatanaka, H
Abe, Y
Naruke, M
Tokunaga, T
Oshika, Y
Kawakami, T
Osada, H
Nagata, J
Kamochi, J
Tsuchida, T
Kijima, H
Yamazaki, H
Inoue, H
Ueyama, Y
Nakamura, M
Citation: H. Hatanaka et al., Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer, CLIN CANC R, 7(5), 2001, pp. 1287-1292
Authors:
Kawakami, T
Tokunaga, T
Hatanaka, H
Tsuchida, T
Tomii, Y
Osada, H
Onoda, N
Morino, F
Nagata, J
Kijima, H
Yamazaki, H
Abe, Y
Osamura, Y
Ueyama, Y
Nakamura, M
Citation: T. Kawakami et al., Interleukin 10 expression is correlated with thrombospondin expression anddecreased vascular involvement in colon cancer, INT J ONCOL, 18(3), 2001, pp. 487-491
Authors:
Kozaki, K
Koshikawa, K
Tatematsu, Y
Miyaishi, O
Saito, H
Hida, T
Osada, H
Takahashi, T
Citation: K. Kozaki et al., Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis, ONCOGENE, 20(31), 2001, pp. 4228-4234
Authors:
Haruki, N
Saito, H
Harano, T
Nomoto, S
Takahashi, T
Osada, H
Fujii, Y
Takahashi, T
Citation: N. Haruki et al., Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 inhuman lung cancers, CANCER LETT, 162(2), 2001, pp. 201-205
Authors:
Sodeoka, M
Sampe, R
Kojima, S
Baba, Y
Usui, T
Ueda, K
Osada, H
Citation: M. Sodeoka et al., Synthesis of a tetronic acid library focused on inhibitors of tyrosine anddual-specificity protein phosphatases and its evaluation regarding VHR andCdc25B inhibition, J MED CHEM, 44(20), 2001, pp. 3216-3222
Citation: L. Nie et al., A facile and effective screening method for p21(WAF1) promoter activators from microbial metabolites, J ANTIBIOT, 54(10), 2001, pp. 783-788
Authors:
Kakeya, H
Kageyama, S
Nie, L
Onose, R
Okada, G
Beppu, T
Norbury, CJ
Osada, H
Citation: H. Kakeya et al., Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium sp., J ANTIBIOT, 54(10), 2001, pp. 850-854
Authors:
Honda, Y
Ueki, M
Okada, G
Onose, R
Usami, R
Horikoshi, K
Osada, H
Citation: Y. Honda et al., Isolation, and biological properties of a new cell cycle inhibitor, curvularol, isolated from Curvularia in sp RK97-F166, J ANTIBIOT, 54(1), 2001, pp. 10-16
Authors:
Osada, H
Tatematsu, Y
Masuda, A
Saito, T
Sugiyama, M
Yanagisawa, K
Takahashi, T
Citation: H. Osada et al., Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylationin lung cancer cell lines, CANCER RES, 61(22), 2001, pp. 8331-8339
Authors:
Haruki, N
Harano, T
Masuda, A
Kiyono, T
Takahashi, T
Tatematsu, Y
Shimizu, S
Mitsudomi, T
Konishi, H
Osada, H
Fujii, Y
Takahashi, T
Citation: N. Haruki et al., Persistent increase in chromosome instability in lung cancer - Possible indirect involvement of p53 inactivation, AM J PATH, 159(4), 2001, pp. 1345-1352
Authors:
Masuda, A
Osada, H
Yatabe, Y
Kozaki, K
Tatematsu, Y
Takahashi, T
Hida, T
Takahashi, T
Takahashi, T
Citation: A. Masuda et al., Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments, AM J PATH, 158(1), 2001, pp. 87-96
Citation: S. Simizu et H. Osada, Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines, NAT CELL BI, 2(11), 2000, pp. 852-854
Authors:
Sanz-Cervera, JF
Stocking, EM
Usui, T
Osada, H
Williams, RM
Citation: Jf. Sanz-cervera et al., Synthesis and evaluation of microtubule assembly inhibition and cytotoxicity of prenylated derivatives of cyclo-L-Trp-L-Pro, BIO MED CH, 8(10), 2000, pp. 2407-2415
Authors:
Ganesh, S
Agarwala, KL
Ueda, K
Akagi, T
Shoda, K
Usui, T
Hashikawa, T
Osada, H
Delgado-Escueta, AV
Yamakawa, K
Citation: S. Ganesh et al., Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes, HUM MOL GEN, 9(15), 2000, pp. 2251-2261
Authors:
Hamaguchi, T
Takahashi, A
Kagamizono, T
Manaka, A
Sato, M
Osada, H
Citation: T. Hamaguchi et al., Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2-[(4-methylthiopyridin-2-yl)methylsufinyl]benzimidazole, BIOORG MED, 10(23), 2000, pp. 2657-2660
Authors:
Yanagisawa, K
Uchida, K
Nagatake, M
Masuda, A
Sugiyama, M
Saito, T
Yamaki, K
Takahashi, T
Osada, H
Citation: K. Yanagisawa et al., Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers, ONCOGENE, 19(19), 2000, pp. 2305-2311